Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda

J Acquir Immune Defic Syndr. 2010 Dec;55(4):491-4. doi: 10.1097/QAI.0b013e3181e8d5a8.

Abstract

Background: High prevalences of reduced glomerular filtration rate (GFR) have been reported from HIV-infected individuals in sub-Saharan Africa when initiating antiretroviral therapy. However little is known about natural history HIV-related kidney disease or about background rates of reduced GFR in HIV-negative individuals in this region.

Methods: We estimated GFR from first and last available stored serum samples from 1202 HIV-infected and 664 age-matched and sex-matched HIV-negative individuals in a community-based cohort of HIV-infected and HIV-negative individuals in Rakai, Uganda, between 1994 and 2003. We assessed the prevalence and incidence of mildly (60-89 ml·min·1.73 m) and moderately (<60 ml·min·1.73 m) reduced GFR using standard analytical methods.

Results: At baseline, 8.4% of HIV-infected and 4.7% of HIV-negative individuals had mildly or moderately reduced GFR (P = 0.002). During follow-up, the rates of decline to a lower GFR category were of 32.4 and 20.3 per 1000 person-years in HIV-infected and HIV-negative subjects, respectively (P = 0.019).

Conclusions: In an unselected community sample of HIV-infected individuals followed in Rakai, Uganda, before the availability of antiretroviral therapy, the prevalence of decreased GFR and the incidence of a decline in GFR category during follow-up were both significantly higher in HIV-infected subjects compared with HIV-negative subjects, although moderately reduced GFR was uncommon.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • Chronic Disease
  • Cohort Studies
  • Female
  • Glomerular Filtration Rate*
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / physiopathology*
  • HIV Seronegativity
  • HIV-1*
  • Humans
  • Incidence
  • Kidney / physiopathology*
  • Kidney Diseases / epidemiology
  • Kidney Diseases / physiopathology*
  • Kidney Diseases / virology*
  • Male
  • Prevalence
  • Uganda / epidemiology

Substances

  • Anti-Retroviral Agents